Johnson & Johnson Receivables 2012-2026 | JNJ

Johnson & Johnson receivables for the quarter ending March 31, 2026 were $17.178B, a 15.74% increase year-over-year.

  • Johnson & Johnson receivables for 2025 were $17.178B, a 15.74% increase from 2024.
  • Johnson & Johnson receivables for 2024 were $14.842B, a 0.21% decline from 2023.
  • Johnson & Johnson receivables for 2023 were $14.873B, a 5.94% increase from 2022.

Johnson & Johnson Receivables 2012-2026 | JNJ

  • Johnson & Johnson receivables for 2025 were $17.178B, a 15.74% increase from 2024.
  • Johnson & Johnson receivables for 2024 were $14.842B, a 0.21% decline from 2023.
  • Johnson & Johnson receivables for 2023 were $14.873B, a 5.94% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B